Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Published: December 7, 2025 Inovio Pharmaceuticals (NASDAQ: INO) has quietly turned 2025 into a make‑or‑break year. The small‑cap biotech has completed a Biologics License Application (BLA) for its lead DNA immunotherapy INO‑3107, raised fresh capital through two stock offerings, and attracted a flurry of new analyst ratings and algorithmic “Strong Buy” labels — all while still burning cash and generating minimal revenue. GuruFocus+3Yahoo Finance+3Stock Titan+3 As of the last trading session on Friday, December 5, 2025, INO stock closed at $2.07, up about 2.5% on the day and roughly 19–20% over the past 10 trading sessions, with around 1 million
Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Ticker: LUV – Coverage date: December 7, 2025 Southwest Airlines stock is back in the spotlight. As of the close on Friday, December 5, 2025, shares of Southwest Airlines Co. (NYSE: LUV) finished just under $38, near a new 52‑week high, after rallying roughly 20% over the past month and about 12–13% year to date.MarketBeat+1 The catch: this surge comes right after the airline cut its 2025 profit outlook because of a 43‑day U.S. government shutdown and higher fuel costs—and just as U.S. regulators waive an $11 million fine tied to Southwest’s infamous 2022 holiday meltdown.Reuters+1 Here’s a detailed look
7 December 2025
CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (NASDAQ: CLSK) has quietly turned into one of the loudest volatility machines in U.S. small caps: a Bitcoin miner, an emerging AI infrastructure play, and a stock that can move nearly 10% in a day without breaking a sweat. As of the close on December 5, 2025, CLSK traded around $13.7 per share, down roughly 8–9% on the day on very heavy volume of about 32–33 million shares. The selloff followed the release of “transformative” fiscal 2025 results that delivered triple‑digit revenue growth and a swing to substantial profit – but also missed Wall Street estimates and came with
KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

Updated: December 7, 2025 – Ticker: KULR (NYSE American) KULR Stock Snapshot: Price, Market Cap, and Volatility At the start of December 2025, KULR Technology Group’s share price is hovering around $3.93, with recent trading showing an intraday range between roughly $3.78 and $3.99 and volume around 1.36 million shares. That puts the company’s market capitalization near $180 million. Stock Titan Those calm-looking numbers sit on top of a pretty wild story: In other words, KULR is not a sleepy industrial. It’s a mash‑up of space‑grade battery tech and a leveraged Bitcoin balance sheet, and the stock trades accordingly. What
Uzbekistan’s €9.46 Billion Green Energy Leap: 42 Projects, 2 Billion kWh of Solar and a Rebuff to Fossil Fuel Politics

Uzbekistan’s €9.46 Billion Green Energy Leap: 42 Projects, 2 Billion kWh of Solar and a Rebuff to Fossil Fuel Politics

A New Energy Story Out of Central Asia While much of the global debate on energy still revolves around fossil fuels, one landlocked Central Asian country has started to quietly redraw the map. In the first week of December 2025, Uzbekistan unveiled a sweeping package of renewable energy and grid projects, deepened partnerships with Saudi and other foreign investors, and disclosed new figures showing that small-scale solar panels alone have already generated nearly 2 billion kWh of electricity this year.qazinform.com+1 The scale and speed of these changes have drawn international attention. A widely shared analysis on CleanTechnica goes as far
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of the close on 5 December 2025, BP’s New York–listed ADRs (NYSE: BP) traded around $35.8 per share, while the London‑listed stock (LSE: BP.) changed hands at about 453p, putting the UK shares up roughly 18% over the past year.StockAnalysis+1 TradingView estimates BP’s dividend yield at about 5.4%, cementing its status as a high‑income name in the FTSE 100.TradingView Yet on
7 December 2025
Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Published: December 7, 2025 Nike’s stock has had a choppy 2025, and as of early December the story is less about sneakers and more about strategy: a leadership overhaul, pressure in China, a fresh dividend increase and a market still trying to decide whether NKE is a turnaround play or a value trap. Nike (NKE) Stock Price Snapshot Today Nike’s Class B shares (ticker: NKE) are trading around $65.86 per share, giving the company a market capitalization of roughly $97 billion. Google Key snapshot metrics as of this week: According to Zacks, the stock is down about 11% over the
7 December 2025
StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

As of December 7, 2025, sneakerheads, collectors and private‑market investors are all watching the same thing: “StockX stock”—even though the company still isn’t publicly listed on any exchange. StockX, the Detroit‑based marketplace that brands itself as the “stock market of things,” remains a private, venture‑backed company. But a growing ecosystem of pre‑IPO platforms, secondary brokers and data providers now publishes daily “StockX stock prices” and valuation estimates, and the company has just wrapped a busy 2025 filled with new products, legal milestones and impressive marketplace growth. AltInvests+1 This article pulls together the latest prices, news, forecasts and analyses around StockX
7 December 2025
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt offering, secured fresh regulatory wins in its cardiopulmonary and animal-health franchises, boosted its dividend, and simultaneously ran into a new patent roadblock for its subcutaneous Keytruda injection in Germany. PR Newswire+4Wikipedia+4Stock Titan+4 Against that backdrop, MRK stock is trading near the top of its 52‑week range, and Wall Street is sharpening its forecasts for 2026 and beyond. MRK stock price
Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Published: December 7, 2025 As the first full week of December wraps up, the Dow Jones Industrial Average is pressing up against the 48,000 line, sitting within striking distance of its all‑time highs. Investors are simultaneously cheering cooling inflation and a coming Federal Reserve rate cut, while parsing a thicket of 2026 forecasts that range from “bull market continues” to “recession risk rising.” This mix of optimism and unease is shaping the Dow Jones stock market narrative going into a pivotal week for Wall Street. Where the Dow Jones Stands Now The Dow Jones Industrial Average closed Friday, December 5,
7 December 2025
IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

As of December 7, 2025 The iShares Russell 2000 ETF (ticker: IWM) is back near its highs, trading around $250.77 after a powerful rebound in U.S. small‑cap stocks. The fund now sits close to its 52‑week peak near $252, up in the mid‑teens on a year‑to‑date basis, and well above its 52‑week low near $172. Investing.com+2Danelfin AI+2 At the same time, investors have poured billions into IWM, options activity has surged, and Wall Street strategists are suddenly bullish on small caps heading into 2026. So is IWM stock at the start of a new leadership cycle—or just another head fake
7 December 2025
NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

Data and news current as of 7 December 2025. NVAX stock price now: where Novavax stands in December 2025 Novavax, Inc. (NASDAQ: NVAX) closed on Friday, 5 December 2025 at $6.91 per share, giving the vaccine maker a market value of around $1.1 billion.Novavax Investor Relations+1 Over the last year, NVAX has slipped roughly 20%, according to data from Investing.com and other market trackers.Investing.com+1 That’s modest compared with its longer-term collapse: Simply Wall St calculates that Novavax shares are down about 94% over the past five years, even after a flurry of recent milestones.Simply Wall St+1 Key trading stats as
7 December 2025
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock remains volatile, heavily shorted, and hotly debated on Wall Street. AlphaSense+1 This article rounds up the latest Upstart stock news, earnings, forecasts and analysis as of December 7, 2025, for readers tracking UPST on Google News and Discover. Upstart (UPST) stock price today: volatile AI lender with high short interest Upstart closed at about $46.75 per share in recent trading,
AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie’s stock is trading just below record highs as investors digest a powerful mix of rising earnings, a fresh dividend increase and a steady drumbeat of positive pipeline news in immunology, neuroscience and oncology. As of the close on Friday, December 5, 2025, AbbVie (NYSE: ABBV) finished at $226.08, down about 1.15% on the day and roughly 7–8% below its 52‑week high of $244.81 set on October 1.MarketWatch+1 That still leaves the company with a market capitalization around $400 billion, firmly placing it among the largest healthcare stocks globally.The Motley Fool+1 Below is a deep dive into the latest news,
Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar Inc. (NYSE: CAT) goes into December 7, 2025 as one of the surprise “AI winners” of the year — even though it makes machines that move rock and dirt, not lines of code. The stock is trading a little above $600 per share, around $603, hovering near its record highs in the low $600s. Over the past year, CAT has climbed roughly 50%, with gains of more than 65% year‑to‑date and over 70% in the last six months, pushing its market cap beyond $270 billion. Yahoo Finance+3Investing.com+3TradingView+3 That kind of move naturally triggers the big investor questions: Let’s walk
7 December 2025
Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Updated December 7, 2025 – for information only, not investment advice. Novo Nordisk stock today: from market darling to turnaround story Novo Nordisk (NYSE: NVO), the Danish giant behind GLP‑1 blockbusters Wegovy and Ozempic, has gone from Europe’s most valuable listed company to a bruised turnaround story in 2025. For investors, NVO has abruptly shifted from a “can do no wrong” growth icon to a complex mix of structural strengths (dominant GLP‑1 franchise, deep pipeline, global reach) and cyclical headaches (pricing pressure, competition, R&D setbacks). The Alzheimer’s shock: EVOKE and EVOKE+ miss their goal The biggest single blow of 2025
Visa Stock (V) Outlook as of December 7, 2025: HQ Move, AI PayLater Card and Legal Risks Shape 2026 Forecast

Visa Stock (V) Outlook as of December 7, 2025: HQ Move, AI PayLater Card and Legal Risks Shape 2026 Forecast

Published: December 7, 2025 Visa Inc. (NYSE: V) is trading around $331 per share as of early December 2025, roughly 12% below its 2025 high near $375 and about 11% above its 52‑week low around $299. With a market value in the mid‑$600 billion range and trailing revenue of $40 billion, the payments giant remains one of the most profitable and dominant franchises in global finance – but the stock now sits at the crossroads of regulatory pressure, fresh growth initiatives, and a still‑premium valuation. StockAnalysis+2Q4 CDN+2 Visa stock today: price, valuation and trading backdrop Visa’s latest closing price near
7 December 2025
IFC’s $50 Million Bet on Gujarat Fluorochemicals to Build India’s First Integrated Battery Materials Plant

IFC’s $50 Million Bet on Gujarat Fluorochemicals to Build India’s First Integrated Battery Materials Plant

New Delhi / Gujarat, December 7, 2025 — The International Finance Corporation (IFC), the private-sector arm of the World Bank Group, has committed around US$50 million to GFCL EV Products Ltd, a subsidiary of Gujarat Fluorochemicals Ltd (GFL) of the INOXGFL Group, to build India’s first fully integrated battery materials manufacturing facility at Jolva, near Bharuch in Gujarat.ETAuto.com+1 The greenfield project is designed to localise a large share of the lithium‑ion battery value chain within India, strengthen domestic supply chains for electric vehicles (EVs) and energy storage systems (ESS), and cut reliance on imported battery materials that currently come largely
7 December 2025
Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

As of the close on Friday, December 5, 2025, Rivian Automotive (NASDAQ: RIVN) stock traded around $17.95, just below a new 52‑week high of $18.17, giving the EV maker a market value of roughly $21.5 billion.MarketBeat+1 That price is 30–45% higher than a year ago, even after a major recall of nearly 35,000 electric delivery vans and multiple rounds of layoffs, but still about 90% below its post‑IPO peak.24/7 Wall St.+1 Here’s how the latest news, forecasts and analyses as of December 7, 2025 stack up for RIVN stock. Rivian stock today: price action and sentiment MarketBeat’s forecast page shows
Interstellar Comet 3I/ATLAS Lights Up the Solar System: New Hubble and Juice Images Reveal Jets, Dual Tails and a Puzzling ‘Heartbeat’

Interstellar Comet 3I/ATLAS Lights Up the Solar System: New Hubble and Juice Images Reveal Jets, Dual Tails and a Puzzling ‘Heartbeat’

As of December 7, 2025, interstellar comet 3I/ATLAS has become the most closely watched object in the sky. In just a few days, NASA, ESA and independent astronomers have released a flood of new images and analyses: Hubble’s fresh November 30 portrait, ESA’s Juice spacecraft NavCam teaser, a Psyche mission tracking update, and new scientific work on the comet’s jets, strange sunward “anti‑tail” and 16‑hour brightness rhythm. Wikipedia+3NASA Science+3European Space Agency+3 At the same time, the comet is heading toward its closest approach to Earth on December 19, when it will pass at a safe distance of about 1.8 astronomical
7 December 2025
1 468 469 470 471 472 535

Stock Market Today

SMIC stock set for results test this week as Hong Kong market reopens

SMIC stock set for results test this week as Hong Kong market reopens

8 February 2026
SMIC shares closed up 0.22% at HK$67.60 on Friday in Hong Kong. The board will announce unaudited results on Feb. 10, and shareholders vote Feb. 12 on acquiring the remaining 49% of SMNC. The register of members closes Feb. 9–12. SMIC plans to pay mainly with new RMB shares.
MediaTek stock price drops 3.4% as Taiwan market shuts; what investors watch next week

MediaTek stock price drops 3.4% as Taiwan market shuts; what investors watch next week

8 February 2026
MediaTek shares closed down 3.4% at NT$1,710 on Friday in Taipei, with 11.8 million shares traded before the market shut for the weekend. The company said it will double investment in data-center chips and advanced packaging, while warning of rising supply chain costs. Fourth-quarter sales rose 8.8% to NT$150.2 billion, but net income slipped 3.6%. Investors face uncertainty ahead of the Lunar New Year break and a weaker tech sector mood.
Go toTop